| DIABETES | HYPERTENSION | HYPERCHOLESTEROLEMIA |
International
Classification
Disease
(ICD)
Code |
250 Diabetes
mellitus
250.0 — 250.9
357.2
Polyneuropathy
in diabetes
362.0x Diabetic
retinopathy
366.41 Diabetic
cataract
583.81
Diabetic
nephropathy |
401 — 405
Hypertensive
diseases
401 Essential
hypertension
401.0, 401.1,
401.9
402 Hypertensive
heart disease
403 Hypertensive
renal disease
404 Hypertensive
heart and
renal disease
405 Secondary
hypertension |
272 Disorder of lipoid
metabolism
272.0 Pure hypercholes-
terolemia
272.2 Mixed
hyperlipidemia
272.3 Hyperchylo-
micronemia
272.4 Other |
Current
Procedural
Terminology
(CPT) |
82947-82950
Glucose
82951-82952
Tolerance test
82962 Glucose by
monitor device
83036 HgbA |
N/A |
80061 Lipid panel
82465 Cholesterol,
serum total
83715, 83717 Lipoprotein
83718 Lipoprotein, HDL
83721 Lipoprotein, LDL |
American
Hospital Formulary
System
(AHFS) |
68:20 Antidiabetic
agents
68:20:08 Insulins
68:20:20
Sulfonylureas
68:20:92
Antidiabetic
agents, other |
24:00 Cardiovascular
drugs
24:08 Hypotensive
agents
40:28 Diuretics |
24:06
Antilipemic agents |
United
States
Pharma-
ceutical
(USP)/VA
Medicine
Classification
System |
HS500 Blood
glucose
regulation agents
HS501 Insulin
HS502
Hypoglycemic
agents, oral
HS503
Antihypoglycemics |
CV100 Beta
blockers/related
CV150 Alpha
blockers/related
CV200 Ca++
channel blockers
CV400 Antihypertensives,
combo
CV490 Antihypertensives,
other
CV700 Diuretics
CV701 Thiazides
CV702 Loop
diuretics
CV703 Carbonic
anhydrase inhibitors
CV704 Potassium-
sparing
CV709 Other
CV800 ACE
inhibitors
CV805 ACE II
inhibitors |
CV350
Antilipemic
agents |
